Navigation Links
PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com
Date:7/23/2014

NEW YORK, July 23, 2014 /PRNewswire/ -- PositiveID Corp. (OTCQB: PSID), based in Delray Beach, Fla., is an emerging player in the bio-threat detection market, that develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security ("DHS") Science & Technology directorate, and $30 million of contract funding.

The Company is nearing initial revenue recognition and the recent first ever issuance of revenue guidance by management builds confidence that progress is being made and that we have visibility to deployment of the Company's products. The Company issued revenue guidance through the end of 2015 of $4-10 million (combined between 2014 and 2015), $3.5 million of which is already in backlog.  

An analyst report by Small Cap IR detailing the current situation, summary and investment thesis, an overview of the company background, product review, current customers, recent developments, risk factors and analyst recommendation can be viewed in its entirety by using the link below. There is no cost required to view this report:

http://bit.ly/-PSID-AnalystResearchReport

copy and paste to browser may be required.

FORWARD-LOOKING DISCLAIMER   

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.   

COMPLIANCE PROCEDURE   

Content is researched, written and reviewed on a best-effort basis. This document, article or report is written and authored by Michael Anderegg, Chartered Financial Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.

A full disclaimer can be found by viewing the full analyst report.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcaptraders.com. For any urgent concerns or inquiries please contact us at editor@smallcaptraders.com.

Contact: editor@smallcaptraders.com


'/>"/>
SOURCE SmallCapTraders.com
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune
2. CVS Caremark Provides Long-Term Enterprise Growth Strategy and 2014 Guidance at Annual Analyst Day
3. CVS Caremark To Host 2013 Analyst Day For The Investment Community
4. MEI Pharma To Host Analyst And Investor Day
5. Cyberonics To Webcast Presentations From Companys Investor And Analyst Meeting
6. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
7. Frost & Sullivan Hosts Analyst Briefing: An Outlook of Azerbaijan and Iran Healthcare Markets
8. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
9. Compass Diversified Holdings to Host Investor and Analyst Event On June 12, 2013
10. Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalDatas 700 Market Analysts
11. The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... de 2016  A Proliant Biologicals anuncia, com ... bovina (BSA -- Bovine Serum Albumin ) ... Norte da Nova Zelândia, em Feilding. ... da Proliant nos EUA, localizada em ... dos equipamentos foram feitos de forma a reproduzir ...
(Date:2/11/2016)... , Ill. and INDIANAPOLIS , Feb. ... for many young people, but for those with type ... only do these students juggle class schedules, assignments and ... living with type 1 diabetes. On top of that, ... time. Diabetes Scholars Foundation (Foundation) Lilly ...
(Date:2/11/2016)... , February 11, 2016 ... release of a new research report, titled "Sports Medicine Devices ... Forecast, 2013 - 2019". According to the report, the global ... 4.40% CAGR from 2013 to 2019, growing from a value ... --> --> The global ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
(Date:2/11/2016)... NY (PRWEB) , ... February 11, 2016 , ... ... enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, to include ... in vein illumination with an estimated 85% share of the market, facilitates adherence ...
(Date:2/11/2016)... ... 11, 2016 , ... The annual list showcases the 20 Most Promising SharePoint ... dedication and commitment to the SharePoint ecosystem. A panel of experts and members ... is to recognize and promote technology entrepreneurship. , The survey was made at ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... ergoFET force gauges used in physical therapy, occupational therapy and sports medicine clinics, ... resistance cord exercise and therapy, introduces its new microFET Digital Pinch Gauge. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... in significantly higher rates of several common cancer screenings, especially among women. Cancer ... outcomes and survival rates. , The study,“What Does Medicaid Expansion Mean for ...
Breaking Medicine News(10 mins):